OpenMed/multicare-articles huggingface dataset:
Whole genome and transcriptome sequencing of a B3 thymoma
Authors: Iacopo Petrini, Arun Rajan, Trung Pham, Donna Voeller, Sean Davis, James Gao, Yisong Wang, Giuseppe Giaccone
Journal: PLoS One (2013)
MeSH terms: Gene Expression Profiling, Genomics, Sequence Analysis, DNA, Sequence Analysis, RNA, Thymoma / genetics, Thymoma / pathology, Case Reports, Research Support, N.I.H., Intramural, Base Sequence, DNA Copy Number Variations / genetics, Female, Humans, Middle Aged, Mutation, Neoplasm Staging, Thymoma / diagnostic imaging, Thymus Neoplasms / diagnostic imaging, Thymus Neoplasms / genetics, Thymus Neoplasms / pathology, Tomography, X-Ray Computed

Molecular pathology of thymomas is poorly understood. Genomic aberrations are frequently identified in tumors but no extensive sequencing has been reported in thymomas. Here we present the first comprehensive view of a B3 thymoma at whole genome and transcriptome levels. A 55-year-old Caucasian female underwent complete resection of a stage IVA B3 thymoma. RNA and DNA were extracted from a snap frozen tumor sample with a fraction of cancer cells over 80%. We performed array comparative genomic hybridization using Agilent platform, transcriptome sequencing using HiSeq 2000 (Illumina) and whole genome sequencing using Complete Genomics Inc platform. Whole genome sequencing determined, in tumor and normal, the sequence of both alleles in more than 95% of the reference genome (NCBI Build 37). Copy number (CN) aberrations were comparable with those previously described for B3 thymomas, with CN gain of chromosome 1q, 5, 7 and X and CN loss of 3p, 6, 11q42.2-qter and q13. One translocation t(11;X) was identified by whole genome sequencing and confirmed by PCR and Sanger sequencing. Ten single nucleotide variations (SNVs) and 2 insertion/deletions (INDELs) were identified; these mutations resulted in non-synonymous amino acid changes or affected splicing sites. The lack of common cancer-associated mutations in this patient suggests that thymomas may evolve through mechanisms distinctive from other tumor types, and supports the rationale for additional high-throughput sequencing screens to better understand the somatic genetic architecture of thymoma.